{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:35:14Z","timestamp":1761510914434},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1841,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1111\/j.1524-4733.2007.00295.x","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T18:14:05Z","timestamp":1204222445000},"page":"726-732","source":"Crossref","is-referenced-by-count":27,"title":["Survey Assessment of Continuation of and Satisfaction with Pharmacological Treatment for Urinary Incontinence"],"prefix":"10.1016","volume":"11","author":[{"given":"Ulka B.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rich","family":"Barron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1524-4733.2007.00295.x_bib10","author":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2165\/00019053-200523100-00003","article-title":"Pharmacological management of overactive bladder: a systematic and critical review of published economic evaluations","volume":"23","author":"Getsios","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib30","series-title":"Urinary Incontinence in Adults: Acute And Chronic Management","author":"Fantl","year":"1996"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1532-5415.1998.tb02469.x","article-title":"Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type","volume":"46","author":"Thom","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0090-4295(03)00009-8","article-title":"Estimated economic costs of overactive bladder in the United States","volume":"61","author":"Hu","year":"2003","journal-title":"Urology"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0090-4295(97)00623-7","article-title":"Economic costs of urinary incontinence in 1995","volume":"51","author":"Wagner","year":"1998","journal-title":"Urology"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib70","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s001920170096","article-title":"Urge incontinence and detrusor instability","volume":"12","author":"Jabs","year":"2001","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-4295(00)00885-2","article-title":"Practice patterns in the treatment of female urinary incontinence: a postal and internet survey","volume":"57","author":"Kim","year":"2001","journal-title":"Urology"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib90","first-page":"673","article-title":"Pharmacotherapy of urinary incontinence","volume":"54","author":"Mold","year":"1996","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1464-410X.2003.03076.x","article-title":"Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder","volume":"91","author":"Mattiasson","year":"2003","journal-title":"BJU Int"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib110","first-page":"610","article-title":"Prevalence and severity of urinary incontinence in ambulatory adults: an UPRNet study","volume":"36","author":"Lagace","year":"1993","journal-title":"J Fam Pract"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib120","first-page":"109","article-title":"What Americans understand and how they are affected by bladder control problems: highlights of recent nationwide consumer research","volume":"25","author":"Muller","year":"2005","journal-title":"Urol Nurs"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1532-5415.1998.tb02468.x","article-title":"Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking","volume":"46","author":"Roberts","year":"1998","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl.","key":"10.1111\/j.1524-4733.2007.00295.x_bib140","first-page":"S121","article-title":"Persistence with overactive bladder pharmacotherapy in a Medicaid population","volume":"11","author":"Shaya","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib150","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0002-9378(99)70381-9","article-title":"Observed patient compliance with a structured outpatient bladder retraining program","volume":"181","author":"Visco","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib160","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1524-4733.2005.00041.x","article-title":"Persistence and adherence of medications for chronic overactive bladder\/urinary incontinence in the California Medicaid program","volume":"8","author":"Yu","year":"2005","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1098-3015(10)61180-1","article-title":"Utilization patterns associated with tolterodine immediate release versus oxybutinin in the management of urinary incontinence","volume":"5","author":"Boccuzzi","year":"2002","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1098-3015(10)62516-8","article-title":"Patient persistency with medications for overactive bladder","volume":"7","author":"Chui","year":"2004","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1524-4733.2001.40202-247.x","article-title":"Persistence of therapy with drugs for overactive bladder","volume":"4","author":"Zhou","year":"2001","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib200","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0094-0143(21)00523-1","article-title":"Epidemiology and psychosocial aspects of incontinence","volume":"22","author":"Diokno","year":"1995","journal-title":"Urol Clin North Am"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib220","first-page":"2032","article-title":"Reliability and validity of the overactive bladder-patient satisfaction with treatment questionnaire (OAB-PSTQ)","volume":"14","author":"Sissins","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib230","first-page":"2144","article-title":"Development of a patient satisfaction with treatment questionnaire for overactive bladder (OAB-PSTQ)","volume":"14","author":"Barron","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib240","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib250","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br J Urol"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib270","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","article-title":"Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder","volume":"93","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib280","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00002512-200118070-00007","article-title":"Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine","volume":"18","author":"Abrams","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/PL00007094","article-title":"Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine","volume":"19","author":"Appell","year":"2001","journal-title":"World J Urol"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib300","first-page":"2430","article-title":"Impact of a health education intervention in overactive bladder patients","volume":"11","author":"Herschorn","year":"2004","journal-title":"Can J Urol"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib310","first-page":"1","article-title":"Findings of a three-year retrospective study to investigate prevalence and incidence of urinary incontinence and overactive bladder in a typical managed care setting","volume":"20","author":"Day","year":"2000","journal-title":"Pharm Pract Manag Q"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib320","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1185\/030079905X59076","article-title":"Overactive bladder in women: symptom impact and treatment expectations","volume":"21","author":"MacDiarmid","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1524-4733.2007.00295.x_bib330","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0090-4295(03)00144-4","article-title":"Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms","volume":"62","author":"Rodriguez","year":"2003","journal-title":"Urology"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510605505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510605505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T23:38:15Z","timestamp":1630798695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510605505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1098301510605505"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00295.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}